Treatment of hyperacute graft-versus-host disease in mice with cytosine arabinoside.
D000208:Acute Disease; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use*; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000517:prevention & control; D006087:Graft vs Host Reaction / Q000187:drug effects; D017710:Lymphocyte Transfusion; D008722:Methods; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D011344:Procarbazine / Q000627:therapeutic use; D014019:Tissue Donors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003561:Cytarabine; D011344:Procarbazine; D003520:Cyclophosphamide; D008727:Methotrexate